KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER

🇸🇦Saudi Arabia

Country: 🇸🇦Saudi Arabia

Ownership: -

Employees: -

Market Cap: -

Website: http://kaimrc.med.sa/

Clinical Trials

Wireless Monitoring for Clinical Deterioration

Not Applicable

Not yet recruiting

Conditions: Inpatient Facililty Diagnoses

First Posted Date: 2024-10-16

Last Posted Date: 2024-10-16

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 13160

Registration Number: NCT06644599

Viral Etiology of Severe Acute Respiratory InFection in CriticallY Ill Patients Registry

Terminated

Conditions: Severe Acute Respiratory Infection

First Posted Date: 2024-10-04

Last Posted Date: 2024-10-04

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 13

Registration Number: NCT06627166

Locations: 🇸🇦
Intensive Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia

The Effect of Whey Protein Consumption on Hypoglycemia in Adults with Type 1 Diabetes During Fasting Ramadan.

Not Applicable

Completed

Conditions: Type1 Diabetes
Fasting
Nutrition, Healthy

Interventions: Dietary Supplement: Whey protein
Dietary Supplement: no Whey protein

First Posted Date: 2024-09-13

Last Posted Date: 2024-09-13

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 44

Registration Number: NCT06595550

Locations: 🇸🇦
King Abdullah International Research Centre, Jeddah, Saudi Arabia

Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children

Not Applicable

Not yet recruiting

Conditions: Voiding Dysfunction
Children

Interventions: Device: Smart-phone Voiding Diary
Diagnostic Test: Paper voiding diary

First Posted Date: 2024-05-08

Last Posted Date: 2024-05-22

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 100

Registration Number: NCT06404996

Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.

Phase 3

Recruiting

Conditions: Dexmedetomidine
Midazolam
Withdrawal Symptoms
Failure of Extubation

Interventions: Drug: Dexmedetomidine
Drug: Midazolam

First Posted Date: 2022-08-03

Last Posted Date: 2023-04-27

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 430

Registration Number: NCT05485519

Locations: 🇸🇦
King Abdullah Specialist Children Hospital (KASCH), Riyadh, Saudi Arabia

Timing of Thyroxine Dose In Ramadan

Not Applicable

Conditions: Hypothyroidism

Interventions: Other: L-Thyroxine time B (5-15 minutes Before dawn)

First Posted Date: 2022-06-16

Last Posted Date: 2022-06-16

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 250

Registration Number: NCT05421468

Locations: 🇸🇦
Reem Alamoudi, Jeddah, Saudi Arabia
🇸🇦
KingAbullahIMRC, Jeddah, Saudi Arabia

Efficacy and Safety for Different Regimen of VTE Pharmacoprophylaxis Among Severely Burn Patients

Not Applicable

Completed

Conditions: Burns

Interventions: Drug: Unfractionated heparin 5000 U q8 hours
Drug: Enoxaparin 40 mg q24 hours
Drug: Enoxaparin 30 mg q12 hours

First Posted Date: 2022-02-14

Last Posted Date: 2022-12-20

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 20

Registration Number: NCT05237726

Locations: 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia

Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients

Not Applicable

Recruiting

Conditions: Pulmonary Embolism
Deep Vein Thrombosis

Interventions: Diagnostic Test: Proximal lower limb ultrasound

First Posted Date: 2021-11-09

Last Posted Date: 2024-06-27

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 1800

Registration Number: NCT05112705

Locations: 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia

The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19)

Phase 3

Conditions: Moderate Covid19

Interventions: Drug: Leukotriene Receptor Antagonist
Other: Placebo

First Posted Date: 2021-05-04

Last Posted Date: 2021-05-10

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 66

Registration Number: NCT04871828

Locations: 🇸🇦
King Abdulaziz Medical city, MNGHA, Riyadh, Saudi Arabia

Sahoor Meal Regimen for Patients With Type1 Diabetes

Not Applicable

Completed

Conditions: Fasting Hypoglycemia
Type1diabetes

Interventions: Other: Meal timing in relation to time of starting the fast

First Posted Date: 2021-04-29

Last Posted Date: 2022-04-11

Lead Sponsor: King Abdullah International Medical Research Center

Target Recruit Count: 44

Registration Number: NCT04864483

Locations: 🇸🇦
KingAbullahIMRC, Jeddah, Western, Saudi Arabia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy